We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTO
1651
H2O America
HTO
$2.62B
| $7.85M | ﹤0.01% |
138,196
-8,091
| -6% | -$486K |
|
1652
Cactus
WHD
$5.44B
| $7.83M | ﹤0.01% |
379,712
+117,925
| +45% | +$2.05M |
|
|
VRTU
1653
DELISTED
Virtusa Corporation
VRTU
| $7.83M | ﹤0.01% |
241,053
+8,000
| +3% | +$248K |
|
1654
Trustmark
TRMK
$2.75B
| $7.82M | ﹤0.01% |
319,056
+29,207
| +10% | +$703K |
|
1655
First Citizens BancShares
FCNCA
$25.3B
| $7.82M | ﹤0.01% |
19,312
-361
| -2% | -$132K |
|
1656
Supernus Pharmaceuticals
SUPN
$2.77B
| $7.81M | ﹤0.01% |
328,797
+12,943
| +4% | +$286K |
|
1657
ICU Medical
ICUI
$4.61B
| $7.8M | ﹤0.01% |
42,340
+1,305
| +3% | +$259K |
|
1658
Health Catalyst
HCAT
$128M
| $7.77M | ﹤0.01% |
266,256
+121,554
| +84% | +$3.36M |
|
1659
EverQuote
EVER
$906M
| $7.76M | ﹤0.01% |
133,353
+22,396
| +20% | +$1.05M |
|
|
XENT
1660
DELISTED
Intersect ENT, Inc
XENT
| $7.75M | ﹤0.01% |
572,062
-12,289
| -2% | -$143K |
|
|
WCC
1661
WESCO International
WCC
$17.7B
| $7.74M | ﹤0.01% |
220,380
+120,897
| +122% | +$3.61M |
|
1662
Central Garden & Pet Co Class A
CENTA
$2.44B
| $7.71M | ﹤0.01% |
285,275
+18,544
| +7% | +$465K |
|
|
UFS
1663
DELISTED
DOMTAR CORPORATION (New)
UFS
| $7.7M | ﹤0.01% |
364,832
+75,555
| +26% | +$1.64M |
|
1664
LGI Homes
LGIH
$1.4B
| $7.7M | ﹤0.01% |
87,412
-9,068
| -9% | -$636K |
|
1665
CNX Resources
CNX
$5.2B
| $7.69M | ﹤0.01% |
889,451
+114,358
| +15% | +$1.15M |
|
1666
Nuveen ESG 1-5 Year US Aggregate Bond ETF
NUSA
$34.6M
| $7.68M | ﹤0.01% |
300,000
| – | – |
|
1667
MillerKnoll
MLKN
$1.67B
| $7.68M | ﹤0.01% |
325,334
-36,721
| -10% | -$830K |
|
|
SFBS
1668
ServisFirst Bancshares
SFBS
$4.86B
| $7.67M | ﹤0.01% |
214,612
-40,393
| -16% | -$1.33M |
|
1669
Visteon
VC
$2.78B
| $7.67M | ﹤0.01% |
112,029
-7,479
| -6% | -$470K |
|
1670
Rocket Pharmaceuticals
RCKT
$394M
| $7.65M | ﹤0.01% |
365,531
+66,754
| +22% | +$1.2M |
|
1671
Glaukos
GKOS
$10.6B
| $7.65M | ﹤0.01% |
199,093
+3,122
| +2% | +$116K |
|
|
BEAT
1672
DELISTED
BioTelemetry, Inc.
BEAT
| $7.64M | ﹤0.01% |
169,106
-28,263
| -14% | -$1.27M |
|
1673
Customers Bancorp
CUBI
$2.77B
| $7.59M | ﹤0.01% |
631,472
+121,703
| +24% | +$1.36M |
|
1674
Adeia
ADEA
$3.11B
| $7.55M | ﹤0.01% |
1,932,824
+523,610
| +37% | +$1.98M |
|
1675
HDFC Bank
HDB
$121B
| $7.52M | ﹤0.01% |
330,776
+311,934
| +1,656% | +$6.4M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.